Bernhard K Keppler

29PUBLICATIONS
76CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Main group metal chemistryMolecular targetsMedical devicesPsychophysiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|May 22, 2026
Combinational studies of BOLD-100/KP1339 with established chemotherapeutics in gastrointestinal multicellular tumor spheroids.

|Sep 29, 2025
Exploring the Anticancer Properties of 4-Phenylthiazole-Based Ru(II) and Os(II) Metallacycles Featuring 1-Methylimidazole as N-Donor Functionality.

Paul Getreuer, Theresa Mendrina, Steven van Terwingen

|Aug 06, 2025
Selectivity for TP53 signalling drives the mode of action of a highly potent N,O,O-tridentate naphthoquinone-based organo-ruthenium anticancer drug candidate.

Alexander Rosner, Lukas Skos, Theresa Mendrina

|Mar 22, 2024
Einbau von (Bioaktiven) Äquatorialen Liganden in Platin(IV)-Komplexe.

Alexander Kastner, Hemma Schueffl, Patrick A Yassemipour

|Mar 20, 2024
Die Wechselwirkung mit ribosomalen Proteinen begleitet die Stressinduktion des Wirkstoffkandidaten BOLD-100/KP1339 im endoplasmatischen Retikulum.

Benjamin Neuditschko, Anton A Legin, Dina Baier

|Mar 12, 2024
Synthesis and preclinical evaluation of BOLD-100 radiolabeled with ruthenium-97 and ruthenium-103.

B Happl, T Balber, P Heffeter

Pageof 5

Frequent Collaborators

14 joint publications

Michael A Jakupec

10 joint publications

Petra Heffeter

10 joint publications

Walter Berger

9 joint publications

Wolfgang Kandioller